Navigating the World of High-Cost Drugs

by | Jan 27, 2020 | Uncategorized

With a Focus on Biologics

Almost 20 years have passed since private drug plans in Canada first experienced
claims for high-cost biologic drugs. They quickly came to represent a sea-change in both
medical practice (due to their effectiveness) and drug plan management (due to their costs).

Click here to download the entire article.